Patents by Inventor Eric Rheaume

Eric Rheaume has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
    Publication number: 20120021982
    Abstract: The present invention features pharmaceutical compositions and methods of using the pharmaceutical compositions for treating left ventricular diastolic dysfunction. In particular, the pharmaceutical compositions include an apolipoprotein complex comprising a lipid fraction and a protein fraction.
    Type: Application
    Filed: July 19, 2011
    Publication date: January 26, 2012
    Inventors: Jean-Claude Tardif, David Busseuil, Eric Rheaume
  • Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
    Publication number: 20110288072
    Abstract: Use of ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo [4.2.0]octa-1,3,5-trien-7-yl]-methyl }-(methyl)-amino]-propyl}-7,8-dimethoxy-1,3,4,5 -tetrahydro-2H-3-benzazepin-2-one, its addition salts with a pharmaceutically acceptable acid and their hydrates, for obtaining a medicament intended for the treatment of endothelial dysfunction.
    Type: Application
    Filed: July 21, 2011
    Publication date: November 24, 2011
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Vidal Benatar, Guy Lerebours-Pigeonniere, Jean-Claude Tardif, Eric Thorin, Eric Rheaume
  • Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
    Publication number: 20080200450
    Abstract: Use of ivabradine, or 3-{3-[{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-methyl}-(methyl)-amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, its addition salts with a pharmaceutically acceptable acid and their hydrates, for obtaining a medicament intended for the treatment of endothelial dysfunction.
    Type: Application
    Filed: January 11, 2008
    Publication date: August 21, 2008
    Applicant: LES LABORATOIRES SERVIER
    Inventors: Vidal Benatar, Guy Lerebours-Pigeonniere, Jean-Claude Tardif, Eric Thorin, Eric Rheaume